Pediatric Neurology

OVERVIEW

The Pediatric Neurology session aims to provide a comprehensive overview of the latest advancements in diagnosing and managing neurological conditions in children. Focused on neurodevelopmental disorders such as autism spectrum disorders and ADHD, this session will provide valuable insights into emerging research and innovative treatment strategies. By addressing both the clinical challenges and research breakthroughs, we aim to enhance understanding and improve patient outcomes for these prevalent conditions.

Epilepsy and genetic neurological disorders will also be key topics of discussion. Participants will gain insights into recent advancements in the treatment of pediatric epilepsy, including novel medications and surgical interventions. The session will further explore the role of genetics in pediatric neurology, highlighting the impact of genetic research on personalized medicine and the management of genetic disorders. These discussions will underscore the importance of integrating genetic insights into clinical practice to tailor treatments for individual needs.

Additionally, the session will cover cutting-edge neuroimaging techniques and their application in pediatric neurology. Attendees will learn about the latest advancements in imaging technologies and their role in diagnosing and managing complex neurological conditions. We will also discuss pediatric stroke and neuropsychological assessment methods, emphasizing their significance in early detection and targeted intervention. This session aims to equip participants with the latest knowledge and practical skills to advance their practice and improve care for pediatric patients.

Key topics:

Neurodevelopmental Disorders: Understanding conditions like Autism Spectrum Disorders, ADHD, and learning disabilities.
Epilepsy in Children: Diagnosis, management, and the latest treatment options.
Genetic Neurological Disorders: Exploring the role of genetics in pediatric neurology and recent advancements in gene therapy.
Neuroimaging in Pediatrics: Advances in imaging techniques and their implications for diagnosing and treating neurological conditions in children.
Pediatric Stroke: Causes, symptoms, and treatment approaches for strokes occurring in children.
Neuropsychological Assessment: Methods for evaluating cognitive and behavioral functions in pediatric patients.

TOPICS

Key Discussion Areas

Core scientific themes explored across all sessions in this track.

🔬

Interventional Cardiology Advances

Latest techniques in percutaneous coronary intervention, transcatheter structural interventions, and complex bifurcation stenting with outcome data from 2025–2026 trials.

💊

Heart Failure: New Drug Classes

Comprehensive review of SGLT2 inhibitors across HFrEF/HFpEF, mavacamten in HCM, and emerging agents in the pipeline with mechanisms and clinical trial evidence.

🤖

AI in Cardiac Imaging

Clinical validation data for AI tools in echocardiography, cardiac MRI, and CT angiography — including automated ejection fraction, plaque characterisation, and anomaly detection.

🧬

Cardiac Genetics & Cardiomyopathy

CRISPR applications in hereditary cardiomyopathy, genotype-guided risk stratification, and family screening protocols in hypertrophic and dilated cardiomyopathies.

⚡

Arrhythmia & Electrophysiology

Catheter ablation advances in persistent AF, ventricular tachycardia, and SCA prevention strategies including novel antiarrhythmic drug data and wearable monitoring.

🛡️

Preventive Cardiology

Polygenic risk scores in cardiovascular prevention, novel lipid-lowering strategies beyond statins, and population health approaches to primary cardiovascular prevention.

AUDIENCE

Who Should Attend?

This track is designed for clinicians, researchers, and allied health professionals with an interest in pediatric neurology.

Cardiologists and cardiology trainees
Interventional cardiologists
Cardiac electrophysiologists
Heart failure specialists
Cardiothoracic surgeons
Clinical cardiac physiologists
Internal medicine physicians with cardiovascular interest
Cardiovascular nurses and allied health professionals
Cardiovascular researchers and clinical trialists

Attend Pediatric Neurology

Join delegates from 120+ countries for three days of world-class clinical science at the Healthcore Bridge International Medical Conference 2026.

FAQs

Frequently Asked Questions

What is the scope of the Oncology & Haematology track?

The Oncology & Haematology track covers precision oncology, immunotherapy, ADC therapies, haematological malignancies, liquid biopsy and early detection, AI in oncology, and palliative care — across 22 sessions over three conference days. It is the largest scientific track at the 2026 conference.

Will there be separate sessions for haematology and solid tumours?

Yes. The track is structured with dedicated morning sessions for haematological malignancies and afternoon sessions focusing on solid tumour oncology. The final panel each day brings all specialties together for cross-disciplinary discussion.

Are there oncology workshops available?

Yes. Two hands-on workshops complement the oncology track: a molecular tumour board simulation workshop and an AI pathology interpretation masterclass. Both require separate registration due to a 30-delegate capacity limit.

Is this track accredited for oncology-specific CME?

All oncology sessions are accredited for CME under EACCME, AMA PRA Category 1, and the Royal College of Radiologists (for radiation oncologists). Specialty-specific CME credit allocation is detailed in the conference programme and the CME pre-event delegate guide.